BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 19659806)

  • 1. De novo cholangiocarcinoma after liver transplantation in a pediatric patient.
    Channabasappa N; Johnson-Welch S; Mittal N
    Pediatr Transplant; 2010 Dec; 14(8):E110-4. PubMed ID: 19659806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma.
    Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
    Am J Surg Pathol; 2010 Jan; 34(1):27-34. PubMed ID: 19898228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant therapy and liver transplantation for hilar cholangiocarcinoma: is pretreatment pathological confirmation of diagnosis necessary?
    Rosen CB; Darwish Murad S; Heimbach JK; Nyberg SL; Nagorney DM; Gores GJ
    J Am Coll Surg; 2012 Jul; 215(1):31-8; discussion 38-40. PubMed ID: 22621893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cholangiocarcinoma associated with Caroli's disease].
    Yoshikawa K; Ito A; Nishimura M; Kishima H; Ichikawa H; Akagi H; Minami M; Han N; Tsujimura T
    Gan No Rinsho; 1988 Jan; 34(1):73-80. PubMed ID: 2828714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening and diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis.
    Jesudian AB; Jacobson IM
    Rev Gastroenterol Disord; 2009; 9(2):E41-7. PubMed ID: 19668124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current surgical management of hilar and intrahepatic cholangiocarcinoma: the role of resection and orthotopic liver transplantation.
    Petrowsky H; Hong JC
    Transplant Proc; 2009 Dec; 41(10):4023-35. PubMed ID: 20005336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholangiocarcinoma arising in Caroli's disease.
    Phinney PR; Austin GE; Kadell BM
    Arch Pathol Lab Med; 1981 Apr; 105(4):194-7. PubMed ID: 6260057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver transplantation for cholangiocarcinoma.
    Schwartz JJ; Hutson WR; Gayowski TJ; Sorensen JB
    Transplantation; 2009 Aug; 88(3):295-8. PubMed ID: 19667927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis.
    Burak K; Angulo P; Pasha TM; Egan K; Petz J; Lindor KD
    Am J Gastroenterol; 2004 Mar; 99(3):523-6. PubMed ID: 15056096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of disease recurrence following neoadjuvant chemoradiotherapy and liver transplantation for unresectable perihilar cholangiocarcinoma.
    Heimbach JK; Gores GJ; Haddock MG; Alberts SR; Pedersen R; Kremers W; Nyberg SL; Ishitani MB; Rosen CB
    Transplantation; 2006 Dec; 82(12):1703-7. PubMed ID: 17198263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and risk factors for gallbladder neoplasia in patients with primary sclerosing cholangitis: evidence for a metaplasia-dysplasia-carcinoma sequence.
    Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
    Am J Surg Pathol; 2007 Jun; 31(6):907-13. PubMed ID: 17527079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholangiocarcinoma following orthotopic liver transplantation. A unique pattern of recurrence diagnosed using immunohistochemical stains.
    Masada CT; Markin RS
    J Clin Gastroenterol; 1994 Mar; 18(2):155-8. PubMed ID: 8189012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological prognostic factors after hepatectomy for patients with mass-forming type intrahepatic cholangiocarcinoma: relevance of the lymphatic invasion index.
    Shirabe K; Mano Y; Taketomi A; Soejima Y; Uchiyama H; Aishima S; Kayashima H; Ninomiya M; Maehara Y
    Ann Surg Oncol; 2010 Jul; 17(7):1816-22. PubMed ID: 20135355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Carcinoma in situ in localized Caroli's disease].
    Joly I; Choux R; Baroni JL; Payan MJ; Mazel C; Branger D; Ponte J; Sastre B; Sahel J
    Gastroenterol Clin Biol; 1990; 14(1):90-2. PubMed ID: 2311852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study.
    Bergquist A; Glaumann H; Persson B; Broomé U
    Hepatology; 1998 Feb; 27(2):311-6. PubMed ID: 9462625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis.
    Boberg KM; Jebsen P; Clausen OP; Foss A; Aabakken L; Schrumpf E
    J Hepatol; 2006 Oct; 45(4):568-74. PubMed ID: 16879890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrahepatic cholangiocarcinoma arising in Caroli's disease.
    Jang MH; Lee YJ; Kim H
    Clin Mol Hepatol; 2014 Dec; 20(4):402-5. PubMed ID: 25548748
    [No Abstract]   [Full Text] [Related]  

  • 18. Vascular complications after orthotopic liver transplantation after neoadjuvant therapy for hilar cholangiocarcinoma.
    Mantel HT; Rosen CB; Heimbach JK; Nyberg SL; Ishitani MB; Andrews JC; McKusick MA; Haddock MG; Alberts SR; Gores GJ
    Liver Transpl; 2007 Oct; 13(10):1372-81. PubMed ID: 17427173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hilar cholangiocarcinoma and liver transplantation.
    Heimbach J
    Transplantation; 2009 Aug; 88(3):299-300. PubMed ID: 19667928
    [No Abstract]   [Full Text] [Related]  

  • 20. Transplantation for cholangiocarcinoma: when and for whom?
    Rea DJ; Rosen CB; Nagorney DM; Heimbach JK; Gores GJ
    Surg Oncol Clin N Am; 2009 Apr; 18(2):325-37, ix. PubMed ID: 19306815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.